No CrossRef data available.
Published online by Cambridge University Press: 11 March 2020
From a scientific standpoint, the world is more prepared than ever to respond to infectious disease outbreaks; paradoxically, globalization and air travel, antimicrobial resistance, the threat of bioterrorism, and newly emerging pathogens driven by ecological, socioeconomic, and environmental factors, have increased the risk of global epidemics.1,2,3 Following the 2002–2003 severe acute respiratory syndrome (SARS), global efforts to build global emergency response capabilities to contain infectious disease outbreaks were put in place.4,5,6 But the recent H1N1, Ebola, and Zika global epidemics have shown unnecessary delays and insufficient coordination in response efforts.7,8,9,10 In a thoughtful and compelling essay,11 Thana C. de Campos argues that greater clarity in the definition of pandemics would probably result in more timely effective emergency responses, and pandemic preparedness. In her view, a central problem is that the definition of pandemics is based solely on disease transmission across several countries, and not on spread and severity together, which conflates two very different situations: emergency and nonemergency disease outbreaks. A greater emphasis on severity, such that pandemics are defined as severe and rapidly spreading infectious disease outbreaks, would make them “true global health emergencies,” allowing for priority resource allocation and effective collective actions in emergency response efforts. Sympathetic to the position taken by de Campos, here I highlight some of the challenges in the definition of severity during an infectious disease outbreak.
Acknowledgement: This work was partially supported by the Millennium Science Initiative of the Chilean Ministry of Economy, Development, and Tourism, grant ‘Millennium Nucleus for the Study of the Life Course and Vulnerability.’ Study sponsors did not have any role in analysis and interpretation of data; writing the report; or in the decision to submit for publication. I would like to thank Josefina Palacios for thoughtful comments and suggestions.
1. Frieden, TR, Tappero, JW, Dowell, SF, Hien, NT, Guillaume, FD, Aceng, JR. Safer countries through global health security. The Lancet 2014;383(9919):764-6CrossRefGoogle ScholarPubMed.
2. Jones, KE, Patel, NG, Levy, MA, Storeygard, A, Balk, D, Gittleman, JL, et al. Global trends in emerging infectious diseases. Nature 2008;451(7181):990 CrossRefGoogle ScholarPubMed.
3. Hoffman, SJ, Silverberg, SL. Delays in global disease outbreak responses: Lessons from H1N1, Ebola, and Zika. American Journal of Public Health 2018;108(3):329–33CrossRefGoogle ScholarPubMed.
4. See note 3, Hoffman 2018.
5. Hardiman, MC. World Health Organization perspective on implementation of international health regulations. Emerging Infectious Diseases 2012;18(7):1041 CrossRefGoogle ScholarPubMed.
6. Gates, B. The next epidemic—lessons from Ebola. New England Journal of Medicine 2015;372(15):1381–4CrossRefGoogle ScholarPubMed.
7. See note 3, Hoffman 2018.
8. Moon, S, Sridhar, D, Pate, MA, Jha, AK, Clinton, C, Delaunay, S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet 2015;386(10009):2204–21CrossRefGoogle ScholarPubMed.
9. Nuzzo, JB, Cicero, AJ, Inglesby, TV. The importance of continued US investment to sustain momentum toward global health security. JAMA 2017;318(24):2423–4CrossRefGoogle ScholarPubMed.
10. Lucey, DR, Gostin, LO. The emerging Zika pandemic: Enhancing preparedness. JAMA 2016;315(9):865–6CrossRefGoogle ScholarPubMed.
11. de Campos TC. The traditional definition of pandemics, its moral conflations, and its practical implications: A defense of conceptual clarity in global health laws and policies. Cambridge Quarterly of Healthcare Ethics 2020;29(2):206–218.
12. Rosselló, J, Santana-Gallego, M, Awan, W. Infectious disease risk and international tourism demand. Health Policy and Planning 2017;32(4):538–48CrossRefGoogle ScholarPubMed.
13. Frieden, TR, Damon, IK. Ebola in West Africa—CDC’s role in epidemic detection, control, and prevention. Emerging Infectious Diseases 2015;21(11):1897–905CrossRefGoogle ScholarPubMed.
14. Huber, C, Finelli, L, Stevens, W. The economic and social burden of the 2014 Ebola outbreak in West Africa. The Journal of Infectious Diseases 2018;218(suppl_5):S698–S704 CrossRefGoogle ScholarPubMed.
15. Lee, J-W, McKibbin, WJ. Estimating the global economic costs of SARS. In: Learning from SARS: preparing for the next disease outbreak: Workshop summary. Washington, DC: National Academies Press; 2004, at 92Google Scholar.
16. Kostova, D, Cassell, CH, Redd, JT, Williams, DE, Singh, T, Martel, LD, et al. Long-distance effects of epidemics: Assessing the link between the 2014 West Africa Ebola outbreak and U.S. exports and employment. Health Economics 2019:1–14 Google ScholarPubMed.
17. Doshi, P. The elusive definition of pandemic influenza. Bulletin of the World Health Organization 2011;89:532–8CrossRefGoogle ScholarPubMed.
18. Swinburn, BA, Sacks, G, Hall, KD, McPherson, K, Finegood, DT, Moodie, ML, et al. The global obesity pandemic: shaped by global drivers and local environments. The Lancet 2011;378(9793):804–14CrossRefGoogle ScholarPubMed.
19. Warner, K, Mackay, J. The global tobacco disease pandemic: Nature, causes, and cures. Global public health 2006;1(1):65–86 CrossRefGoogle ScholarPubMed.
20. Fineberg, HV. Pandemic preparedness and response—lessons from the H1N1 influenza of 2009. New England Journal of Medicine 2014;370(14):1335–42CrossRefGoogle ScholarPubMed.
21. See note 11, de Campos 2020.
22. See note 11, de Campos 2020
23. See note 13, Frieden 2015.
24. Chowell, G, Viboud, C, Simonsen, L, Merler, S, Vespignani, A. Perspectives on model forecasts of the 2014–2015 Ebola epidemic in West Africa: Lessons and the way forward. BMC Medicine 2017;15(1):42 CrossRefGoogle ScholarPubMed.
25. Meltzer, MI, Santibanez, S, Fischer, LS, Merlin, TL, Adhikari, BB. Modeling in real time during the Ebola response. Morbidity and Mortality Weekly Report 2015;65(3):85–9Google Scholar.
26. Nicoll, A, Ammon, A, Amato, A, Ciancio, B, Zucs, P, Devaux, I, et al. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health 2010;124(1):14–23 Google ScholarPubMed.
27. Peters, DH, Keusch, GT, Cooper, J, Davis, S, Lundgren, J, Mello, MM, et al. In search of global governance for research in epidemics. The Lancet 2017;390(10103):1632–3CrossRefGoogle ScholarPubMed.
28. See note 25, Meltzer 2015.
29. See note 2, Jones 2008.
30. See note 25, Meltzer 2015.
31. World Health Organization (WHO). Emergencies preparedness, response. Disease Outbreak News. In. Geneva: WHO; 2019; available at https://www.who.int/csr/don/en/ (last accessed 5 Nov 2019).
32. See note 31, WHO 2019.
33. See note 24, Chowell 2017.
34. Mercer, GN, Glass, K, Becker, NG. Effective reproduction numbers are commonly overestimated early in a disease outbreak. Statistics in Medicine 2011;30(9):984–94CrossRefGoogle Scholar.
35. Britton, T, Scalia Tomba, G. Estimation in emerging epidemics: Biases and remedies. Journal of The Royal Society Interface 2019;16(150):20180670 CrossRefGoogle ScholarPubMed.
36. See note 6, Gates 2015.
37. Merianos, A, Peiris, M. International health regulations (2005). The Lancet 2005;366(9493):1249–51CrossRefGoogle ScholarPubMed.
38. Undurraga, EA, Carias, C, Meltzer, MI, Kahn, EB. Potential for broad-scale transmission of Ebola virus disease during the West Africa crisis: Lessons for the Global Health security agenda. Infectious Diseases of Poverty 2017;6(1):159 CrossRefGoogle ScholarPubMed.
39. See note 20, Fineberg 2014.
40. Gostin, LO, Friedman, EA. A retrospective and prospective analysis of the west African Ebola virus disease epidemic: Robust national health systems at the foundation and an empowered WHO at the apex. The Lancet 2015;385(9980):1902–9CrossRefGoogle Scholar.
41. See note 8, Moon 2015.
42. See note 9, Nuzzo 2017.
43. See note 1, Frieden 2014.
44. See note 6, Gates 2015.
45. See note 38, Undurraga 2017.
46. Doshi, P. Calibrated response to emerging infections. BMJ 2009;339:b3471Google ScholarPubMed.
47. See note 38, Undurraga 2017.
48. Bogoch, II, Creatore, MI, Cetron, MS, Brownstein, JS, Pesik, N, Miniota, J, et al. Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 West African outbreak. The Lancet 2015;385(9962):29–35 CrossRefGoogle ScholarPubMed.
49. Lessler, J, Chaisson, LH, Kucirka, LM, Bi, Q, Grantz, K, Salje, H, et al. Assessing the global threat from Zika virus. Science 2016;353(6300):aaf8160 CrossRefGoogle ScholarPubMed.
50. Colizza, V, Barrat, A, Barthelemy, M, Vespignani, A. The role of the airline transportation network in the prediction and predictability of global epidemics. Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2015–20CrossRefGoogle ScholarPubMed.
51. Hufnagel, L, Brockmann, D, Geisel, T. Forecast and control of epidemics in a globalized world. Proceedings of the National Academy of Sciences 2004;101(42):15124–9CrossRefGoogle Scholar.
52. See note 17, Doshi 2011.
From a scientific standpoint, the world is more prepared than ever to respond to infectious disease outbreaks; paradoxically, globalization and air travel, antimicrobial resistance, the threat of bioterrorism, and newly emerging pathogens driven by ecological, socioeconomic, and environmental factors, have increased the risk of global epidemics.Footnote 1, Footnote 2, Footnote 3 Following the 2002–2003 severe acute respiratory syndrome (SARS), global efforts to build global emergency response capabilities to contain infectious disease outbreaks were put in place.Footnote 4, Footnote 5, Footnote 6 But the recent H1N1, Ebola, and Zika global epidemics have shown unnecessary delays and insufficient coordination in response efforts.Footnote 7, Footnote 8, Footnote 9, Footnote 10 In a thoughtful and compelling essay,Footnote 11 Thana C. de Campos argues that greater clarity in the definition of pandemics would probably result in more timely effective emergency responses, and pandemic preparedness. In her view, a central problem is that the definition of pandemics is based solely on disease transmission across several countries, and not on spread and severity together, which conflates two very different situations: emergency and nonemergency disease outbreaks. A greater emphasis on severity, such that pandemics are defined as severe and rapidly spreading infectious disease outbreaks, would make them “true global health emergencies,” allowing for priority resource allocation and effective collective actions in emergency response efforts. Sympathetic to the position taken by de Campos, here I highlight some of the challenges in the definition of severity during an infectious disease outbreak.
De Campos asserts that the discussion about accepted definitions of pandemics is not only semantic. In fact, declaring a disease outbreak a ‘pandemic’ has vast global and local implications beyond planning and response efforts, including political, social, and economic consequences.Footnote 12 , Footnote 13 , Footnote 14 , Footnote 15 , Footnote 16 , Footnote 17 A true pandemic, she argues, would need two components: transmissibility and severity. Thus, noncommunicable diseases independent of their severity, such as obesity,Footnote 18 or tobacco addiction,Footnote 19 and nonsevere communicable diseases, should not be considered global health emergencies in the context of pandemic preparedness and response. A pandemic would thus be characterized by sustained transmission across countries,Footnote 20 and a high impact on mortality and morbidity.Footnote 21 In this context, disease spread and severity would establish whether an infectious disease outbreak is a global health emergency or nonemergency, and this would “avoid definitional ambiguities that generate moral confusions.”Footnote 22 Unfortunately, determining the severity of an outbreak is not always straightforward.
The severity of an infectious disease outbreak can be characterized as a function of the virulence or pathogenicity of an agent to cause disease, and on its transmissibility, often operationalized as the expected number of new cases generated by an infected individual. Transmissibility is affected by the modes of transmission of an agent, susceptibility or exposure of potential hosts, and/or the duration of patients’ infectivity. But in some ways, the ‘severity’ of a disease also depends on the characteristics of local communities, including early detection and response capabilities, healthcare facilities, health workers, preventive technologies, communications, and community awareness. For example, a quick diagnosis, adequate isolation, and good infection control practices can be the difference between life and death for an Ebola infected patient, as was shown by Ebola patients treated in the USA during the 2014–2016 West Africa crisis. The large majority of those patients survived.
Perhaps the exclusion of severity in the definition of pandemics reflects the difficulties of estimating the real impact of an outbreak early on, when the local and global communities need to provide a timely and effective response, and does not reflect a lack of political will, of understanding the importance of a clearer definition, or even political and financial interests. Modellers working in emergency response typically need to predict the expected size, duration, and effects of an outbreak at an early stage. Some of the challenges they face include poor data quality and limited data availability (for example, inadequate epidemiological and clinical surveillance, reporting delays, poor epidemic research governance), short turnaround times, difficulty in communicating results (for example, interpretation of estimates, model assumptions, uncertainty), insufficient understanding of the pathogen and its transmission dynamics (for example, natural history of disease, modes of transmission, human mobility and exposure, contact networks), limited or unavailable specific and sensitive diagnostic tests, uncertainty in the effectiveness, impact, and costs of countermeasures, and several layers of complexity in international collaboration.Footnote 23 , Footnote 24 , Footnote 25 , Footnote 26 , Footnote 27 Reliable data are essential for determining outbreak severity, but are often not available.Footnote 28
Most resources for detecting and responding to emerging disease outbreaks are globally allocated in high-income countries, where major infectious disease outbreaks are less likely to occur.Footnote 29 For example, in the past decade the World Health Organization has reported about 300 infectious disease outbreaks, from limited local outbreaks to global events involving several thousand deaths across various countries, such as the 2014–2016 Ebola outbreak in West Africa.Footnote 30 , Footnote 31 Most of these infectious disease outbreaks have occurred in low- and middle-income countries, often in areas with limited disease surveillance and response capabilities.Footnote 32
There is thus substantial uncertainty about the scope and duration of most epidemics, and of their potential effects, particularly during the early phases of the outbreak when response efforts need to be planned and coordinated, and funding secured. Understandably, there might be a tendency for public health officials and/or disease experts to err on the side of caution, and overestimate the expected impact of epidemics. But at least for modellers, there is evidence for both overestimating and underestimating the size of an epidemic, largely because emergency response requires estimates at the emerging phase of an outbreak, when data may be sparse or of poor quality.Footnote 33 , Footnote 34 , Footnote 35
Administrative, logistical, scientific, and political complexities are part of any local or global emergency response; yet the world lacks a global institution to coordinate response efforts, with corresponding funding, and authority to make decisions.Footnote 36 De Campos highlights the role of International Health Regulations (IHR), a multilateral treaty adopted by all members of the World Health Organization “to prevent, protect against, control, and provide a public health response to the international spread of disease.”Footnote 37 The IHR went into effect in 2007, and required countries to generate capabilities, including human resources, disease surveillance, emergency management, and laboratory infrastructure, to be able to rapidly detect and effectively respond to infectious disease outbreaks.Footnote 38 But the H1N1 influenza in 2009 and, five years later, the 2014–2016 Ebola crisis showed that few countries had complied with IHR.Footnote 39 , Footnote 40 These epidemics thus highlighted the urgent need for a response system for public health emergencies.Footnote 41 , Footnote 42 The lack of a coordinating institution adds uncertainty about the global capacity to set up a coherent, effective, organized, and sustained response, and limits the usability of severity-based definitions. Achieving adequate local and global preparedness to set up a proportionate precautionary response requires a reasonable characterization and understanding of an epidemic. Probably the most sustainable way of doing this is by strengthening local public health systems, including healthcare infrastructure, health personnel, disease surveillance, and laboratory capabilities. Improving local infectious disease detection and response preparedness capabilities not only helps prevent and stop an outbreak before it becomes a pandemic, it also promotes population health and well-being.Footnote 43 , Footnote 44 , Footnote 45 Epidemic responses could then be adapted to local conditions of disease transmission and severity.Footnote 46
Recent infectious disease outbreaks have highlighted the increasing risk of pandemics in a tightly interconnected world.Footnote 47 , Footnote 48 , Footnote 49 , Footnote 50 , Footnote 51 Despite adoption of the IHR treaty, many countries do not have the capabilities needed to rapidly detect and effectively respond to infectious disease outbreaks. Further, there are substantial gaps in the scientific knowledge required to characterize the threat of emergent pathogens—such as the Zika, SARS, Ebola, or influenza viruses—with confidence, and often available data are inadequate for accurately estimating the potential spread and severity of an outbreak at an early stage. I concur with de Campos’ thesis that the standard definition of pandemics may be inadequate for both theoretical and practical purposes, and that a combination of both transmission across countries and severity (i.e., high morbidity and mortality) of an outbreak would allow distinguishing between emergency and nonemergency situations. I have tried to highlight some of challenges toward the goal of achieving this conceptual clarity, not to discourage the goal, but to help set a plausible pathway. As illustrated by Peter DoshiFootnote 52 for the influenza outbreaks that have been labelled ‘pandemic,’ it can be challenging to standardize severity. It can be even harder to predict it.